|
|
Article: Organizational models evolve to meet advancing drug discovery technology. (Life Sciences).
- Article from:
- Chemical Market Reporter
- Article date:
- March 10, 2003
- Author:
CopyrightCOPYRIGHT 2003 Schnell Publishing Company, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
THE TECHNOLOGICAL advances of the past decade are puffing greater pressure on the organizational models of the drug development industry, particularly for big pharmaceutical companies. To ramp up efficiency, players are tightening the links between discovery, development and commercialization. This retooling and innovation from biotechnology will drive new drugs in the next two to three years, say a group of senior industry executives who spoke at the Biotechnology Industry Organization's (BIO) annual CEO and Investor Conference, held last month in New York.
"We are now challenged by developing the capabilities and fostering the creativity to use an unprecedented ...